Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/03/20 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 04/03/20 | 3 | Initial statement of beneficial ownership of securities |
|
3 | |
| 04/03/20 | 3 | Initial statement of beneficial ownership of securities |
|
3 | |
| 04/03/20 | 8-K | Current report filing |
|
116 | |
| 04/02/20 | EFFECT | Notice of Effectiveness |
|
1 | |
| 03/31/20 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 03/31/20 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
12 | |
| 03/30/20 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/27/20 | 8-K | Current report filing |
|
3 | |
| 03/26/20 | 8-K | Current report filing |
|
3 |
